retatrutide injection frequency A Clinician's Guide to Dosing VisualAbstract: Retatrutide reduces body weight

Kim W, Egan JM

Once completed, eligible patients are scheduled for a virtual consultation and may begin treatment quickly

The case report literature on GLP-1 agonists and anorgasmia identifies decreased norepinephrine signaling as a potential contributor to orgasmic dysfunction, which represents a separate but related concern from decreased desire

Book your appointment today to take the first step toward a healthier, more confident you

Editors note: This report has been updated to reflect findings from the TRIUMPH-1 clinical trial released on May 21, 2026 by Eli Lilly and Company.

Cagrilintide: What the Evidence Actually Shows The pivotal standalone human dataset for cagrilintide is a multicentre, randomised, double-blind, placebo- and active-controlled, dose-finding Phase 2 trial in people with overweight or obesity